-
Emapalumab, sold
under the
brand name Gamifant, is an anti-interferon-gamma (IFNγ)
antibody medication used for the
treatment of
hemophagocytic lymphohistiocytosis...
-
Vedolizumab L04AG06
Alemtuzumab L04AG07
Begelomab L04AG08
Ocrelizumab L04AG09
Emapalumab L04AG10
Inebilizumab L04AG11
Anifrolumab L04AG12
Ofatumumab L04AG13 Teprotumumab...
-
November 2018, the FDA
approved the anti-IFN-gamma
monoclonal antibody emapalumab (proprietary name Gamifant) for the
treatment of
pediatric and
adult primary...
-
IFNGR (γ, II) Agonists:
Interferon gamma (IFN-γ)
Interferon gamma 1b Antibodies:
Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
-
IFNGR (γ, II) Agonists:
Interferon gamma (IFN-γ)
Interferon gamma 1b Antibodies:
Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
-
IFNGR (γ, II) Agonists:
Interferon gamma (IFN-γ)
Interferon gamma 1b Antibodies:
Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
-
IFNGR (γ, II) Agonists:
Interferon gamma (IFN-γ)
Interferon gamma 1b Antibodies:
Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
-
Haemophagocytic Lymphohistiocytosis - Full Text View - ClinicalTrials.gov". "
Emapalumab -
NovImmune - AdisInsight". adisinsight.springer.com. "Pipeline - NI-1401...
-
IFNGR (γ, II) Agonists:
Interferon gamma (IFN-γ)
Interferon gamma 1b Antibodies:
Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
-
IFNGR (γ, II) Agonists:
Interferon gamma (IFN-γ)
Interferon gamma 1b Antibodies:
Emapalumab Fontolizumab IFNLR (λ, III) See IL-28R (IFNLR) here instead....
